Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Frljak

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Biomedicines|December 9, 2020
Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic ReviewCecilie Hoeeg, Sabina Frljak, Abbas Ali Qayyum, et al.
Journal of Cardiovascular Development and Disease|September 26, 2025
Renal Response to Levosimendan in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation Predicts Early Postoperative Renal Function CourseGregor Zemljic, Gregor Poglajen, Sabina Frljak, et al.
Cell Transplantation|July 6, 2018
Transendocardial CD34<sup>+</sup> Cell Transplantation in Noncompaction Cardiomyopathy: First-in-Man Case StudyAndraz Cerar, Gregor Zemljic, Sabina Frljak, et al.
Diagnostics (Basel, Switzerland)|August 1, 2020
Long-Term Effects of Angiotensin Receptor-Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection FractionGregor Poglajen, Ajda Anžič-Drofenik, Gregor Zemljič, et al.
European Journal of Heart Failure|July 1, 2022
A pilot clinical trial of cell therapy in heart failure with preserved ejection fractionBojan Vrtovec, Sabina Frljak, Gregor Poglajen, et al.
Biomedicines|November 27, 2025
SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort TrialAndraž Cerar, Gregor Poglajen, Gregor Zemljič, et al.
Journal of Cardiac Failure|August 16, 2016
Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart FailureGregor Zemljic, Gregor Poglajen, Matjaz Sever, et al.
JHLT Open|June 15, 2026
Management of Tacrolimus-induced thrombotic microangiopathy in a heart transplant recipient: Utilizing novel immunosuppression strategiesPetra Girandon Sušanj, Renata Okrajšek, Sabina Frljak, et al.
Stem Cells Translational Medicine|March 16, 2017
Effects of Transendocardial CD34<sup>+</sup> Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated CardiomyopathyMojca Bervar, Mirta Kozelj, Gregor Poglajen, et al.
Circulation Research|June 9, 2018
Effects of Repetitive Transendocardial CD34<sup>+</sup> Cell Transplantation in Patients With Nonischemic Dilated CardiomyopathyBojan Vrtovec, Gregor Poglajen, Matjaz Sever, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biomedicines|December 9, 2020
Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic ReviewCecilie Hoeeg, Sabina Frljak, Abbas Ali Qayyum, et al.
Journal of Cardiovascular Development and Disease|September 26, 2025
Renal Response to Levosimendan in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation Predicts Early Postoperative Renal Function CourseGregor Zemljic, Gregor Poglajen, Sabina Frljak, et al.
Cell Transplantation|July 6, 2018
Transendocardial CD34<sup>+</sup> Cell Transplantation in Noncompaction Cardiomyopathy: First-in-Man Case StudyAndraz Cerar, Gregor Zemljic, Sabina Frljak, et al.
Diagnostics (Basel, Switzerland)|August 1, 2020
Long-Term Effects of Angiotensin Receptor-Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection FractionGregor Poglajen, Ajda Anžič-Drofenik, Gregor Zemljič, et al.
European Journal of Heart Failure|July 1, 2022
A pilot clinical trial of cell therapy in heart failure with preserved ejection fractionBojan Vrtovec, Sabina Frljak, Gregor Poglajen, et al.
Biomedicines|November 27, 2025
SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort TrialAndraž Cerar, Gregor Poglajen, Gregor Zemljič, et al.
Journal of Cardiac Failure|August 16, 2016
Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart FailureGregor Zemljic, Gregor Poglajen, Matjaz Sever, et al.
JHLT Open|June 15, 2026
Management of Tacrolimus-induced thrombotic microangiopathy in a heart transplant recipient: Utilizing novel immunosuppression strategiesPetra Girandon Sušanj, Renata Okrajšek, Sabina Frljak, et al.
Stem Cells Translational Medicine|March 16, 2017
Effects of Transendocardial CD34<sup>+</sup> Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated CardiomyopathyMojca Bervar, Mirta Kozelj, Gregor Poglajen, et al.
Circulation Research|June 9, 2018
Effects of Repetitive Transendocardial CD34<sup>+</sup> Cell Transplantation in Patients With Nonischemic Dilated CardiomyopathyBojan Vrtovec, Gregor Poglajen, Matjaz Sever, et al.
Pageof 3